Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ODYSSEY Study: An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM

NCT07867886 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT07867886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07867886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ODYSSEY Study: An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2029
Enrollment
30 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioblastoma